Litcius/Paper detail

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands

A. Kant, Jurriaan R.G. Jansen, Leontine van Balveren, Florence van Hunsel

2022Drug Safety58 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePharmacovigilanceCoronavirus disease 2019 (COVID-19)Adverse Event Reporting SystemAdverse effectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Vaccine safetyImmunization2019-20 coronavirus outbreakCohortCoronavirusPopulationDiseasePediatricsVirologyEnvironmental healthImmunologyInternal medicineInfectious disease (medical specialty)OutbreakAntigenSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyPharmacovigilance and Adverse Drug Reactions
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands | Litcius